The UAB Division of Gynecologic Oncology (GYN/ONC) serves as a major referral center for patients with gynecologic cancers in the state of Alabama, as well as the Southeast. We are a multidisciplinary team of specialty physicians, nurses, and consultants providing comprehensive, compassionate care in treating women's cancers. The division provides access to immediate consultations, ovarian and endometrial cancer risk assessment, advanced abdominal-pelvic and minimally invasive surgical procedures including robotics, expert gynecologic cancer pathologists, comprehensive chemotherapy infusion services, rapid radiation oncology consultations, cutting-edge clinical trials, and supportive care services.

GYN/ONC actively participates in the training of medical students and residents within the department. The division has a well-established Fellowship training program. The fellowship is structured to provide fellows with comprehensive clinical and surgical training and to prepare each fellow for a career in academic gynecologic oncology. The fellowship selection process identifies candidates with clinical and surgical aptitude, as well as interest and demonstrated ability in basic, translational or clinical research.

The division has an extensive portfolio of funded basic and translational research in gynecologic cancer. The division was a founding member of the NCI0funded Gynecologic Oncology Group (GOG) and offers our patients access to cutting-edge clinical trials sponsored by the NRG/GOG and other leading pharmaceutical companies. The division is well known for its ovarian cancer research in gene therapeutics and novel monoclonal antibodies, and previously held a NCI-funded Ovarian Cancer Special Program of Research Excellence (SPORE). The division is also well known for its expertise in cervical cancer prevention and treatment and currently holds, in collaboration with Johns Hopkins, the only NCI-funded Cervical Cancer SPORE.

The volume of patients, the excellence in education, and the breadth and depth of research in gynecologic cancers truly distinguishes the division as one of the leaders in gynecologic cancer in the country.